Has2 Rat (R)-carnitine multiple interactions ISO Has2 (Mus musculus) 6480464 Carnitine inhibits the reaction [Cyclophosphamide results in decreased expression of HAS2 mRNA] CTD PMID:37863343 Has2 Rat (R)-carnitine increases expression ISO Has2 (Mus musculus) 6480464 Carnitine results in increased expression of HAS2 mRNA CTD PMID:37863343 Has2 Rat 1,2-dimethylhydrazine increases expression ISO Has2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of HAS2 mRNA CTD PMID:22206623 Has2 Rat 1,4-phenylenediamine increases expression ISO HAS2 (Homo sapiens) 6480464 4-phenylenediamine results in increased expression of HAS2 mRNA and 4-phenylenediamine results in increased expression of HAS2 protein CTD PMID:31226360 Has2 Rat 1-chloro-2,4-dinitrobenzene increases expression ISO HAS2 (Homo sapiens) 6480464 Dinitrochlorobenzene results in increased expression of HAS2 mRNA and Dinitrochlorobenzene results in increased expression of HAS2 protein CTD PMID:31226360 Has2 Rat 15-acetyldeoxynivalenol increases expression ISO HAS2 (Homo sapiens) 6480464 15-acetyldeoxynivalenol results in increased expression of HAS2 mRNA CTD PMID:23792671 Has2 Rat 17beta-estradiol multiple interactions ISO HAS2 (Homo sapiens) 6480464 ESR1 protein affects the reaction [Estradiol results in decreased expression of HAS2 mRNA] CTD PMID:14699072 Has2 Rat 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of HAS2 mRNA CTD PMID:26496021 Has2 Rat 17beta-estradiol affects expression ISO HAS2 (Homo sapiens) 6480464 Estradiol affects the expression of HAS2 mRNA CTD PMID:14699072 Has2 Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Has2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Has2 Rat 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Has2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Has2 Rat 2,2',5,5'-tetrachlorobiphenyl increases expression ISO HAS2 (Homo sapiens) 6480464 2 more ... CTD PMID:36804509 Has2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HAS2 mRNA CTD PMID:32109520 Has2 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Has2 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 Has2 Rat 2-bromohexadecanoic acid multiple interactions ISO HAS2 (Homo sapiens) 6480464 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HAS2 protein] CTD PMID:38195004 Has2 Rat 2-palmitoylglycerol increases expression ISO HAS2 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of HAS2 mRNA CTD PMID:37199045 Has2 Rat 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:32119087 Has2 Rat 3,4-dichloroaniline increases expression ISO HAS2 (Homo sapiens) 6480464 3 and 4-dichloroaniline results in increased expression of HAS2 mRNA CTD PMID:24172598 Has2 Rat 4,4'-sulfonyldiphenol increases expression ISO Has2 (Mus musculus) 6480464 bisphenol S results in increased expression of HAS2 mRNA CTD PMID:30951980 Has2 Rat 4-nonylphenol multiple interactions ISO HAS2 (Homo sapiens) 6480464 [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of HAS2 mRNA CTD PMID:23626723 Has2 Rat 4-tert-Octylphenol multiple interactions ISO HAS2 (Homo sapiens) 6480464 [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of HAS2 mRNA CTD PMID:23626723 Has2 Rat 5-aza-2'-deoxycytidine affects expression ISO HAS2 (Homo sapiens) 6480464 Decitabine affects the expression of HAS2 mRNA CTD PMID:17145863 Has2 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of HAS2 mRNA CTD PMID:24780913 Has2 Rat 7,12-dimethyltetraphene increases expression ISO Has2 (Mus musculus) 6480464 9 more ... CTD PMID:32553695 Has2 Rat 8-Br-cAMP increases expression ISO HAS2 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HAS2 mRNA CTD PMID:20147733 Has2 Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of HAS2 mRNA CTD PMID:31881176 Has2 Rat acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of HAS2 mRNA CTD PMID:28959563 Has2 Rat aflatoxin B1 decreases methylation ISO HAS2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of HAS2 gene CTD PMID:27153756 Has2 Rat all-trans-retinoic acid multiple interactions ISO HAS2 (Homo sapiens) 6480464 Tretinoin promotes the reaction [CREBBP protein binds to HAS2 promoter] more ... CTD PMID:17307735 Has2 Rat all-trans-retinoic acid multiple interactions ISO Has2 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HAS2 mRNA CTD PMID:36189433 Has2 Rat all-trans-retinoic acid decreases expression ISO HAS2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of HAS2 mRNA CTD PMID:21934132 Has2 Rat all-trans-retinoic acid increases expression ISO Has2 (Mus musculus) 6480464 Tretinoin results in increased expression of HAS2 mRNA CTD PMID:16604517 Has2 Rat all-trans-retinoic acid increases expression ISO HAS2 (Homo sapiens) 6480464 Tretinoin results in increased expression of HAS2 mRNA CTD PMID:17307735 Has2 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of HAS2 mRNA CTD PMID:16483693 Has2 Rat antirheumatic drug decreases expression ISO HAS2 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of HAS2 mRNA CTD PMID:24449571 Has2 Rat aristolochic acid A decreases expression ISO HAS2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of HAS2 mRNA CTD PMID:33212167 Has2 Rat arsane multiple interactions ISO HAS2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HAS2 mRNA CTD PMID:32525701 Has2 Rat arsenic atom multiple interactions ISO HAS2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HAS2 mRNA CTD PMID:32525701 Has2 Rat arsenite(3-) multiple interactions ISO Has2 (Mus musculus) 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of HAS2 mRNA CTD PMID:15894712 Has2 Rat arsenite(3-) decreases expression ISO Has2 (Mus musculus) 6480464 arsenite results in decreased expression of HAS2 mRNA CTD PMID:15894712 and PMID:18929588 Has2 Rat arsenous acid decreases expression ISO HAS2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of HAS2 mRNA CTD PMID:25258189 and PMID:26705709 Has2 Rat benzo[a]pyrene decreases expression ISO Has2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of HAS2 mRNA CTD PMID:15894712 Has2 Rat benzo[a]pyrene multiple interactions ISO HAS2 (Homo sapiens) 6480464 [AHR gene mutant form affects the susceptibility to Benzo(a)pyrene] which results in increased expression of HAS2 mRNA CTD PMID:38036013 Has2 Rat benzo[a]pyrene decreases methylation ISO HAS2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of HAS2 5' UTR CTD PMID:27901495 Has2 Rat benzo[a]pyrene increases expression ISO Has2 (Mus musculus) 6480464 Benzo(a)pyrene metabolite results in increased expression of HAS2 mRNA CTD PMID:32553695 Has2 Rat benzo[a]pyrene multiple interactions ISO Has2 (Mus musculus) 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of HAS2 mRNA CTD PMID:15894712 Has2 Rat benzo[a]pyrene diol epoxide I decreases expression ISO HAS2 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 Has2 Rat bis(2-ethylhexyl) phthalate decreases expression ISO HAS2 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of HAS2 mRNA CTD PMID:31163220 Has2 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO Has2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HAS2 mRNA CTD PMID:39150890 Has2 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of HAS2 mRNA and [bisphenol A co-treated with Testosterone] results in increased expression of HAS2 mRNA CTD PMID:26496021 Has2 Rat bisphenol A decreases expression ISO Has2 (Mus musculus) 6480464 bisphenol A results in decreased expression of HAS2 mRNA CTD PMID:35479511 Has2 Rat bisphenol A multiple interactions ISO HAS2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of HAS2 gene CTD PMID:31601247 Has2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of HAS2 mRNA CTD PMID:34947998 Has2 Rat bisphenol A increases expression ISO Has2 (Mus musculus) 6480464 bisphenol A results in increased expression of HAS2 mRNA CTD PMID:30951980 Has2 Rat bisphenol A decreases expression ISO HAS2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of HAS2 mRNA CTD PMID:27685785 more ... Has2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HAS2 mRNA CTD PMID:25181051 and PMID:30816183 Has2 Rat bisphenol F increases expression ISO Has2 (Mus musculus) 6480464 bisphenol F results in increased expression of HAS2 mRNA CTD PMID:30951980 Has2 Rat buta-1,3-diene decreases expression ISO Has2 (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of HAS2 mRNA CTD PMID:29038090 Has2 Rat butylated hydroxyanisole multiple interactions ISO Has2 (Mus musculus) 6480464 Butylated Hydroxyanisole inhibits the reaction [LHB protein results in increased abundance of HAS2 mRNA] CTD PMID:21220312 Has2 Rat Butylbenzyl phthalate multiple interactions ISO Has2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HAS2 mRNA CTD PMID:39150890 Has2 Rat cadmium atom multiple interactions ISO HAS2 (Homo sapiens) 6480464 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HAS2 protein] more ... CTD PMID:35301059 and PMID:38195004 Has2 Rat cadmium dichloride multiple interactions ISO HAS2 (Homo sapiens) 6480464 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HAS2 protein] more ... CTD PMID:35301059 and PMID:38195004 Has2 Rat calcitriol increases expression ISO HAS2 (Homo sapiens) 6480464 Calcitriol results in increased expression of HAS2 mRNA CTD PMID:16002434 Has2 Rat cannabidiol increases expression ISO HAS2 (Homo sapiens) 6480464 Cannabidiol results in increased expression of HAS2 mRNA CTD PMID:33244087 Has2 Rat carbon nanotube increases expression ISO Has2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Has2 Rat cisplatin decreases expression ISO HAS2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of HAS2 mRNA CTD PMID:27392435 Has2 Rat cisplatin multiple interactions ISO HAS2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of HAS2 mRNA CTD PMID:27392435 Has2 Rat copper atom multiple interactions ISO HAS2 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of HAS2 mRNA CTD PMID:20971185 Has2 Rat copper(0) multiple interactions ISO HAS2 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of HAS2 mRNA CTD PMID:20971185 Has2 Rat crocidolite asbestos increases expression ISO HAS2 (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased expression of HAS2 mRNA CTD PMID:18687144 and PMID:24160326 Has2 Rat crocidolite asbestos affects expression ISO HAS2 (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of HAS2 mRNA CTD PMID:25757056 Has2 Rat cyclophosphamide multiple interactions ISO Has2 (Mus musculus) 6480464 Carnitine inhibits the reaction [Cyclophosphamide results in decreased expression of HAS2 mRNA] CTD PMID:37863343 Has2 Rat cyclophosphamide decreases expression ISO Has2 (Mus musculus) 6480464 Cyclophosphamide results in decreased expression of HAS2 mRNA CTD PMID:37863343 Has2 Rat cyclosporin A decreases expression ISO HAS2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of HAS2 mRNA CTD PMID:38729283 Has2 Rat cyclosporin A multiple interactions ISO HAS2 (Homo sapiens) 6480464 Cyclosporine inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of HAS2 mRNA] CTD PMID:38729283 Has2 Rat cytarabine decreases expression ISO HAS2 (Homo sapiens) 6480464 Cytarabine results in decreased expression of HAS2 mRNA CTD PMID:21198554 Has2 Rat dexamethasone decreases expression ISO HAS2 (Homo sapiens) 6480464 Dexamethasone results in decreased expression of HAS2 mRNA CTD PMID:19609316 Has2 Rat dexamethasone decreases expression ISO Has2 (Mus musculus) 6480464 Dexamethasone results in decreased expression of HAS2 mRNA CTD PMID:22733784 Has2 Rat diallyl trisulfide increases expression ISO HAS2 (Homo sapiens) 6480464 diallyl trisulfide results in increased expression of HAS2 mRNA CTD PMID:34995734 Has2 Rat diarsenic trioxide decreases expression ISO HAS2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of HAS2 mRNA CTD PMID:25258189 and PMID:26705709 Has2 Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of HAS2 mRNA CTD PMID:24893172 Has2 Rat dibutyl phthalate multiple interactions ISO Has2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HAS2 mRNA CTD PMID:39150890 Has2 Rat diethyl phthalate multiple interactions ISO Has2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HAS2 mRNA CTD PMID:39150890 Has2 Rat diisobutyl phthalate multiple interactions ISO Has2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HAS2 mRNA CTD PMID:39150890 Has2 Rat diisononyl phthalate multiple interactions ISO Has2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HAS2 mRNA CTD PMID:39150890 Has2 Rat dioxygen decreases expression ISO HAS2 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of HAS2 mRNA CTD PMID:24236059 Has2 Rat diuron increases expression ISO HAS2 (Homo sapiens) 6480464 Diuron metabolite results in increased expression of HAS2 mRNA CTD PMID:24172598 Has2 Rat dorsomorphin multiple interactions ISO HAS2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Has2 Rat doxorubicin decreases expression ISO HAS2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of HAS2 mRNA CTD PMID:29803840 Has2 Rat doxorubicin increases expression ISO HAS2 (Homo sapiens) 6480464 Doxorubicin results in increased expression of HAS2 mRNA CTD PMID:30031762 Has2 Rat enalapril increases expression EXP 6480464 Enalapril results in increased expression of HAS2 mRNA CTD PMID:20933085 Has2 Rat fluoranthene multiple interactions ISO Has2 (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of HAS2 mRNA and SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HAS2 mRNA] CTD PMID:28329830 Has2 Rat formaldehyde decreases expression ISO HAS2 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of HAS2 mRNA CTD PMID:17938736 and PMID:20655997 Has2 Rat FR900359 increases phosphorylation ISO HAS2 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of HAS2 protein CTD PMID:37730182 Has2 Rat fulvestrant multiple interactions ISO HAS2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of HAS2 gene CTD PMID:31601247 Has2 Rat genistein decreases expression ISO HAS2 (Homo sapiens) 6480464 Genistein results in decreased expression of HAS2 mRNA CTD PMID:22228119 Has2 Rat glutathione multiple interactions ISO Has2 (Mus musculus) 6480464 Glutathione inhibits the reaction [LHB protein results in increased abundance of HAS2 mRNA] CTD PMID:21220312 Has2 Rat glycidol decreases expression EXP 6480464 glycidol results in decreased expression of HAS2 mRNA CTD PMID:24395379 Has2 Rat hyaluronic acid increases chemical synthesis ISO HAS2 (Homo sapiens) 6480464 HAS2 protein results in increased chemical synthesis of Hyaluronic Acid CTD PMID:11318944 Has2 Rat hyaluronic acid affects abundance ISO Has2 (Mus musculus) 6480464 HAS2 protein affects the abundance of Hyaluronic Acid CTD PMID:31285260 Has2 Rat hyaluronic acid multiple interactions ISO HAS2 (Homo sapiens) 6480464 [IL1B protein results in increased expression of HAS2 protein] which results in increased chemical synthesis of Hyaluronic Acid CTD PMID:11318944 Has2 Rat hydrogen peroxide increases expression ISO Has2 (Mus musculus) 6480464 Hydrogen Peroxide results in increased expression of HAS2 mRNA CTD PMID:21220312 Has2 Rat hydrogen peroxide multiple interactions ISO Has2 (Mus musculus) 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Hydrogen Peroxide results in increased expression of HAS2 mRNA] and U 0126 inhibits the reaction [Hydrogen Peroxide results in increased expression of HAS2 mRNA] CTD PMID:21220312 Has2 Rat Inotodiol increases expression ISO HAS2 (Homo sapiens) 6480464 inotodiol results in increased expression of HAS2 mRNA CTD PMID:37628993 Has2 Rat ketoconazole increases expression ISO HAS2 (Homo sapiens) 6480464 Ketoconazole results in increased expression of HAS2 mRNA CTD PMID:36621641 Has2 Rat lovastatin increases expression ISO HAS2 (Homo sapiens) 6480464 Lovastatin results in increased expression of HAS2 mRNA CTD PMID:38432573 Has2 Rat methylisothiazolinone increases expression ISO HAS2 (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of HAS2 mRNA CTD PMID:31629900 Has2 Rat methylmercury chloride decreases expression ISO HAS2 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of HAS2 mRNA CTD PMID:23179753 Has2 Rat methylparaben decreases expression ISO HAS2 (Homo sapiens) 6480464 methylparaben results in decreased expression of HAS2 mRNA CTD PMID:17186576 Has2 Rat mono(2-ethylhexyl) phthalate affects expression ISO Has2 (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate affects the expression of HAS2 mRNA CTD PMID:21195148 Has2 Rat mono(2-ethylhexyl) phthalate multiple interactions ISO Has2 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of HAS2 mRNA CTD PMID:36189433 Has2 Rat mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of HAS2 mRNA and mono-(2-ethylhexyl)phthalate results in decreased expression of HAS2 protein CTD PMID:36889213 Has2 Rat mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of HAS2 mRNA] CTD PMID:36889213 Has2 Rat Monobutylphthalate affects expression ISO Has2 (Mus musculus) 6480464 monobutyl phthalate affects the expression of HAS2 mRNA CTD PMID:21195148 Has2 Rat N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO Has2 (Mus musculus) 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Hydrogen Peroxide results in increased expression of HAS2 mRNA] and N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [LHB protein results in increased abundance of HAS2 mRNA] CTD PMID:21220312 Has2 Rat N-acetyl-L-cysteine multiple interactions ISO Has2 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of HAS2 mRNA] CTD PMID:21220312 Has2 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of HAS2 mRNA CTD PMID:25729387 Has2 Rat oxytocin increases expression EXP 6480464 Oxytocin results in increased expression of HAS2 protein CTD PMID:23707249 Has2 Rat ozone multiple interactions ISO Has2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of HAS2 mRNA more ... CTD PMID:25658374 more ... Has2 Rat ozone increases expression ISO HAS2 (Homo sapiens) 6480464 Ozone results in increased expression of HAS2 mRNA CTD PMID:23033980 Has2 Rat p-tert-Amylphenol multiple interactions ISO HAS2 (Homo sapiens) 6480464 [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of HAS2 mRNA CTD PMID:23626723 Has2 Rat panobinostat multiple interactions ISO HAS2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HAS2 mRNA CTD PMID:27188386 Has2 Rat panobinostat increases expression ISO HAS2 (Homo sapiens) 6480464 panobinostat results in increased expression of HAS2 mRNA CTD PMID:26272509 Has2 Rat PCB138 multiple interactions ISO Has2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Has2 Rat PD 0325901 multiple interactions ISO HAS2 (Homo sapiens) 6480464 [(+)-JQ1 compound co-treated with mirdametinib] results in decreased expression of HAS2 mRNA CTD PMID:25119042 Has2 Rat PD 0325901 decreases expression ISO HAS2 (Homo sapiens) 6480464 mirdametinib results in decreased expression of HAS2 mRNA CTD PMID:25119042 Has2 Rat pentane-2,3-dione increases expression EXP 6480464 2 and 3-pentanedione results in increased expression of HAS2 mRNA CTD PMID:25710175 Has2 Rat perfluorohexanesulfonic acid increases expression ISO Has2 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of HAS2 mRNA CTD PMID:37995155 Has2 Rat potassium chromate increases expression ISO HAS2 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of HAS2 mRNA CTD PMID:22714537 Has2 Rat raloxifene multiple interactions ISO HAS2 (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR1 protein] results in decreased expression of HAS2 mRNA CTD PMID:19059307 Has2 Rat Rutecarpine increases expression ISO HAS2 (Homo sapiens) 6480464 rutecarpine results in increased expression of HAS2 mRNA CTD PMID:34955744 Has2 Rat SB 203580 multiple interactions ISO Has2 (Mus musculus) 6480464 SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HAS2 mRNA] CTD PMID:28329830 Has2 Rat SB 431542 multiple interactions ISO HAS2 (Homo sapiens) 6480464 [4-(5-benzo(1 more ... CTD PMID:21520325 and PMID:27188386 Has2 Rat serpentine asbestos increases expression ISO HAS2 (Homo sapiens) 6480464 Asbestos and Serpentine results in increased expression of HAS2 mRNA CTD PMID:24160326 Has2 Rat silver atom decreases expression ISO Has2 (Mus musculus) 6480464 Silver results in decreased expression of HAS2 mRNA CTD PMID:27131904 Has2 Rat silver(0) decreases expression ISO Has2 (Mus musculus) 6480464 Silver results in decreased expression of HAS2 mRNA CTD PMID:27131904 Has2 Rat sodium arsenate multiple interactions ISO HAS2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HAS2 mRNA CTD PMID:32525701 Has2 Rat sodium arsenite increases expression ISO HAS2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of HAS2 mRNA CTD PMID:28595984 and PMID:34032870 Has2 Rat sodium arsenite decreases expression ISO Has2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of HAS2 mRNA CTD PMID:18812580 and PMID:23732083 Has2 Rat T-2 toxin decreases expression ISO HAS2 (Homo sapiens) 6480464 T-2 Toxin results in decreased expression of HAS2 mRNA CTD PMID:18196609 Has2 Rat T-2 toxin increases expression ISO HAS2 (Homo sapiens) 6480464 T-2 Toxin results in increased expression of HAS2 mRNA CTD PMID:31863870 Has2 Rat tamoxifen multiple interactions ISO HAS2 (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR1 protein] results in decreased expression of HAS2 mRNA CTD PMID:19059307 Has2 Rat tert-butyl hydroperoxide increases expression ISO HAS2 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of HAS2 mRNA CTD PMID:15336504 Has2 Rat testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of HAS2 mRNA CTD PMID:26496021 Has2 Rat tetrachloromethane multiple interactions ISO Has2 (Mus musculus) 6480464 HAS3 protein affects the reaction [Carbon Tetrachloride results in increased expression of HAS2 mRNA] CTD PMID:27042213 Has2 Rat tetrachloromethane increases expression ISO Has2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of HAS2 mRNA CTD PMID:27042213 Has2 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of HAS2 mRNA CTD PMID:34492290 Has2 Rat titanium dioxide increases expression ISO Has2 (Mus musculus) 6480464 titanium dioxide results in increased expression of HAS2 mRNA CTD PMID:23557971 Has2 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of HAS2 mRNA CTD PMID:25729387 Has2 Rat topotecan increases expression EXP 6480464 Topotecan results in increased expression of HAS2 mRNA CTD PMID:25729387 Has2 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of HAS2 mRNA CTD PMID:33387578 Has2 Rat trichostatin A increases expression ISO HAS2 (Homo sapiens) 6480464 trichostatin A results in increased expression of HAS2 mRNA CTD PMID:24935251 and PMID:26272509 Has2 Rat trichostatin A multiple interactions ISO HAS2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HAS2 mRNA CTD PMID:27188386 Has2 Rat triptonide increases expression ISO Has2 (Mus musculus) 6480464 triptonide results in increased expression of HAS2 mRNA CTD PMID:33045310 Has2 Rat tyrphostin AG 1478 multiple interactions EXP 6480464 RTKI cpd inhibits the reaction [LHB protein results in increased expression of HAS2 mRNA] CTD PMID:15459120 Has2 Rat valproic acid decreases expression ISO HAS2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of HAS2 mRNA CTD PMID:23179753 and PMID:28001369 Has2 Rat valproic acid affects expression ISO HAS2 (Homo sapiens) 6480464 Valproic Acid affects the expression of HAS2 mRNA CTD PMID:25979313 Has2 Rat valproic acid increases expression ISO HAS2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of HAS2 mRNA CTD PMID:23179753 more ... Has2 Rat valproic acid multiple interactions ISO HAS2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HAS2 mRNA CTD PMID:27188386 Has2 Rat vorinostat increases expression ISO HAS2 (Homo sapiens) 6480464 vorinostat results in increased expression of HAS2 mRNA CTD PMID:26272509 Has2 Rat vorinostat multiple interactions ISO HAS2 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HAS2 mRNA CTD PMID:27188386